Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer [NA]
Clinical trial evaluating the use of PET/CT for differentiating non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating spatial fragmentation with low-dose radiotherapy in combination with immunotherapy and chemotherapy for chemo-resis…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating canakinumab with chemotherapy, radiation therapy, and durvalumab for non-small cell lung cancer; the stu…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 randomized trial is evaluating the addition of a carbon ion boost for locally advanced non-small cell lung cancer with hypoxic les…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating honokiol in early-stage resectable non-small cell lung cancer is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Hybrid Prehabilitation Before Thoracic Surgery [NA]
This document reports a clinical trial update for a hybrid prehabilitation program before thoracic surgery in non-small cell lung cancer pat…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer
A feasibility study underway at Royal Marsden NHS Foundation Trust aims to collect tissue and blood samples from patients with oncogene-addi…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer [Phase 1]
This clinical trial update describes a Phase 1 study evaluating neoadjuvant chemoimmunotherapy with immunosensitizing radiation for border-l…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Molecular Profiling Project
This clinical trial update indicates that the Molecular Profiling Project led by the National Cancer Centre, Singapore is currently recruiti…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating carbon ion therapy for peripheral non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients [Phase 2]
Phase 2 clinical trial evaluating carbon ion radiotherapy for locally advanced non-small cell lung cancer in elderly patients. The study is …
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer [Phase 2]
A phase 2 neoadjuvant trial of WX-0593 for resectable ALK-positive or ROS1-positive non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer [NA]
The document describes a study to develop and evaluate NodeAI, an AI-powered platform to predict mediastinal lymph node malignancy in real-t…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating stereotactic body radiotherapy (SBRT) followed by neoadjuvant immunochemotherapy in resectable stage II …
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Phase 2 Study of Dacomitinib in NSCLC [Phase 2]
Phase 2 trial evaluating dacomitinib for non-small cell lung cancer (including EGFR-positive NSCLC) is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
This clinical trial investigates plasma molecular profiling to identify resistance mechanisms in ALK-inhibitor resistant non-small cell lung…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
A Pan-Asian clinical database is being established to study EGFR Exon 20 insertion-mutated non-small cell lung cancer, and the study is curr…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC [Phase 3]
Phase 3 clinical trial evaluating D-BACE in combination with chemotherapy and Carelizumab for resectable II-IIIA or potentially resectable T…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of DCTY1102 Injection in patients with advanced solid tumors, including pancreatic ductal adenocarcinoma, colorectal cancer, n…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating neoadjuvant/adjuvant durvalumab for resectable non-small cell lung cancer is currently active and not recruiting.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC [Phase 3]
Phase 3 trial evaluating QL2107 plus chemotherapy versus pembrolizumab (Keytruda) in non-small cell lung cancer is currently recruiting. Spo…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST） [Phase 3]
Phase 3 trial evaluating Firmonertinib versus placebo as adjuvant therapy for stage IB-IIIB non-small cell lung cancer with uncommon EGFR mu…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLC [Phase 2]
Phase 2 trial of trilaciclib in combination with docetaxel for second-line and beyond locally advanced or metastatic non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC. [Phase 2]
Phase II trial evaluating first-line treatment of metastatic squamous non-small cell lung cancer with cisplatin/carboplatin, polymeric micel…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors [Phase 1]
BA1302 from Shandong Boan Biotechnology Co., Ltd is in Phase 1 testing for advanced solid tumors, with non-small cell lung cancer, pancreati…